rs114888195
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2
The NM_004946.3(DOCK2):c.1360G>A(p.Ala454Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000407 in 1,613,862 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004946.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOCK2 | NM_004946.3 | c.1360G>A | p.Ala454Thr | missense_variant | 14/52 | ENST00000520908.7 | NP_004937.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOCK2 | ENST00000520908.7 | c.1360G>A | p.Ala454Thr | missense_variant | 14/52 | 2 | NM_004946.3 | ENSP00000429283.3 |
Frequencies
GnomAD3 genomes AF: 0.00193 AC: 294AN: 152142Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000534 AC: 134AN: 250952Hom.: 0 AF XY: 0.000428 AC XY: 58AN XY: 135606
GnomAD4 exome AF: 0.000248 AC: 363AN: 1461602Hom.: 3 Cov.: 31 AF XY: 0.000238 AC XY: 173AN XY: 727116
GnomAD4 genome AF: 0.00193 AC: 294AN: 152260Hom.: 1 Cov.: 32 AF XY: 0.00185 AC XY: 138AN XY: 74438
ClinVar
Submissions by phenotype
DOCK2 deficiency Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 08, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
DOCK2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 10, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at